Therapeutic neutralizing monoclonal antibody administration protects against lethal viscerotropic Yellow Fever infection
M. J. Ricciardi, L. N. Rust, N. Pedreno-Lopez, S. Yusova, S. Biswas, G. M. Webb, M. Fischer, L. Gonsales-Nieto, T. B. Voigt, J. J. Louw, F. D. Laurino, J. R. DiBello, H.-P. Raue, L. M. S. Raphael, A. Yrizarry-Medina, , B. J. Burwitz
Therapeutic monoclonal antibodies prevent death from YFV infection.
bioRxiv · May 16, 2022 · PreprintImmunology